Biobeat Wearable Patient Monitoring Devices Tested In Acute Ischemic Stroke Patient Clinical Study

Pilot Study Aims to Assess Feasibility and Effectiveness of Monitoring Acute Cerebrovascular Accident Patients with Non-Invasive Continuous Monitoring Devices PETAH TIKVA, Israel, March 1, 2021 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, has announced a collaborative pilot study with Nuvance Health’s Vassar Brothers Medical Center […]

Evasc Neurovascular Announces First Neuro Product Approved in French Forfait Innovation Program

VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular is proud to announce its successful application to France’s Ministry of Health (Haute Autorité de la Santé, HAS) Forfait Innovation (FI) program for the eCLIPs™ device, published in its official journal December 23, 2020 – The Forfait Innovation program grants clinical trial funding to evaluate […]

icometrix expands icobrain portfolio with ischemic stroke solution

LEUVEN, Belgium and BOSTON, Feb. 23, 2021 /PRNewswire/ — icometrix, world leader in imaging AI solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. The announcement follows the FDA-clearance and CE-marking of its image processing software for the analysis and communication of the tissue perfusion state […]

Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan

New Patents to Support Global Partnering of Novel Bio-inspired Clot-dissolving Therapy CAMBRIDGE, MA, February 10, 2021 / B3C newswire / — Thrombolytic Science, LLC (TSI) today announced the granting of three new patents during the last 12 months.  The invention relates to methods and compositions for safe and effective thrombolysis for ischemic […]

Cerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™

FREMONT, Calif. and OXFORD, United Kingdom, Feb. 11, 2021 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Contour Neurovascular System™. Breakthrough Device Designation is granted to medical devices and device-led combination products […]

Live Remote Supervision of Neuroendovascular Surgery Enabled by Olympus MedPresence®

Virtual Presence Solution Provides OR Access to Proctor Required to Oversee Critical Aneurysm Implant Procedure in New Device Trial CENTER VALLEY, Pa., Feb. 11, 2021 /PRNewswire/ — Olympus announced today its cloud-based virtual medical presence platform known as MedPresence® was critical in allowing the first use in the U.S. of a novel intracranial vascular […]

RapidAI Acclaimed by Frost & Sullivan for Its AI-powered Modular Stroke Platform

The technology used in the Rapid® platform is highly unique and scalable and can deliver exceptional cost efficiencies to hospitals of all sizes SANTA CLARA, Calif., Feb. 10, 2021 /PRNewswire/ — Based on its recent analysis of the global intelligent imaging analysis systems market, Frost & Sullivan recognizes RapidAI with the 2020 Global Growth, Innovation & […]

First patient treated in CereVasc clinical trial of eShunt™ System for communicating hydrocephalus

Investigational device has the potential to transform a half-century-old standard of care BOSTON, Feb. 10, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, has treated the first patient in a study of its eShunt System, an investigational device intended to treat communicating […]

RapidAI Cleared in Argentina and Adopted by Top Hospitals to Improve Stroke Imaging and Care

SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced imaging for stroke, today announced it has received registration approval and clearance from Argentina’s Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) for the Rapid imaging platform. Rapid is available to hospitals across Argentina, and already in use at Clínica La […]

Medtronic Announces Early Site Release of New Radial Artery Access Portfolio Following First-in-Patient Procedure

Acquisition of RIST Neurovascular Enhances Medtronic’s Capabilities to Serve Patients Treated for Brain Aneurysms and Other Neurovascular Conditions DUBLIN, Feb. 1, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced expansion of its limited site release of the recently acquired radial artery access portfolio from privately-held RIST Neurovascular, […]